LIU Jin-lai, LI Su-hua. Efficacy and Safety of Evolocumab and Alirocumab in Reducing Lipids and Cardiovascular Events[J]. Journal of Evidence-Based Medicine, 2015, 15(6): 334-338. DOI: 10.3969/j.issn.1671-5144.2015.06.007
|
Citation:
|
LIU Jin-lai, LI Su-hua. Efficacy and Safety of Evolocumab and Alirocumab in Reducing Lipids and Cardiovascular Events[J]. Journal of Evidence-Based Medicine, 2015, 15(6): 334-338. DOI: 10.3969/j.issn.1671-5144.2015.06.007
|
LIU Jin-lai, LI Su-hua. Efficacy and Safety of Evolocumab and Alirocumab in Reducing Lipids and Cardiovascular Events[J]. Journal of Evidence-Based Medicine, 2015, 15(6): 334-338. DOI: 10.3969/j.issn.1671-5144.2015.06.007
|
Citation:
|
LIU Jin-lai, LI Su-hua. Efficacy and Safety of Evolocumab and Alirocumab in Reducing Lipids and Cardiovascular Events[J]. Journal of Evidence-Based Medicine, 2015, 15(6): 334-338. DOI: 10.3969/j.issn.1671-5144.2015.06.007
|
DownLoad: